News
NOTV
8.12
-2.29%
-0.19
Inotiv downgraded to hold at Jefferies on non-human primate supply issues
Seeking Alpha · 01/19 16:18
Jefferies Downgrades Inotiv to Hold, Lowers Price Target to $8
Benzinga · 01/19 10:07
--Jefferies Downgrades Inotiv to Hold From Buy, Adjusts Price Target to $8 From $10
--Jefferies Downgrades Inotiv to Hold From Buy, Adjusts Price Target to $8 From $10
MT Newswires · 01/19 07:13
Inotiv: Turning Focus To Organic Growth
Seeking Alpha · 01/17 09:28
Inotiv: High Expenses Likely To Impair Long-Term Profitability
Seeking Alpha · 01/16 14:10
Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 01/11 18:15
Inotiv stock soars ~20% as FQ4 revenue surges 400%; provides fiscal '23 outlook
Seeking Alpha · 01/11 16:17
Why Inotiv Shares Are Shooting Higher Today
Benzinga · 01/11 15:52
Lipella, Inotiv top healthcare gainers; Tonix, Prenetics among losers
Seeking Alpha · 01/11 15:00
Lake Street Upgrades Inotiv to Buy, Raises Price Target to $10
Benzinga · 01/11 14:13
AMC, BNGO and VXRT are among pre market gainers
Seeking Alpha · 01/11 13:25
--Lake Street Upgrades Inotiv to Buy From Hold, Adjusts Price Target to $10 From $4
--Lake Street Upgrades Inotiv to Buy From Hold, Adjusts Price Target to $10 From $4
MT Newswires · 01/11 11:17
BRIEF-Inotiv Inc Announces Q4 And Full Year Fiscal 2022 Results
Reuters · 01/10 21:16
Inotiv GAAP EPS of -$9.54 misses by $9.16, revenue of $150.5M in-line
Seeking Alpha · 01/10 21:14
Inotiv Q4 EPS $(9.54) Which May Not Compare To $(0.37) Estimate, Sales $150.45M Miss $152.96M Estimate
Benzinga · 01/10 21:07
Inotiv Swings to Loss While Sales Increase in Fiscal Q4 -- Shares Drop After Hours
Inotiv Swings to Loss While Sales Increase in Fiscal Q4 -- Shares Drop After Hours
MT Newswires · 01/10 16:46
-- Earnings Flash (NOTV) INOTIV Reports Q4 Revenue $150.5M
-- Earnings Flash (NOTV) INOTIV Reports Q4 Revenue $150.5M
MT Newswires · 01/10 16:09
$1000 Invested In Inotiv 5 Years Ago Would Be Worth This Much Today
Benzinga · 01/10 14:31
Earnings Outlook For Inotiv
Benzinga · 01/09 14:00
Analyzing Inotiv's Short Interest
Benzinga · 01/03 20:08
More
Webull provides a variety of real-time NOTV stock news. You can receive the latest news about Inotiv Inc through multiple platforms. This information may help you make smarter investment decisions.
About NOTV
Inotiv, Inc. is an international contract research company that is providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Its DSA segment supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Its RMS segment offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.